Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 1Brain Neoplasms 1Anxiety Disorders 1Anatomic Stage IV Breast Cancer AJCC v8 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Specimen Handling 4Docetaxel 3trastuzumab biosimilar HLX02 2pertuzumab 2Trastuzumab 2Taxes 2Paclitaxel 2PF-05280014 2Ontruzant 2Ogivri 2Biopsy 22C4 antibody 2pembrolizumab 1fisetin 1abemaciclib 1Steroids 1Standard of Care 1Rifaximin 1Radiation Dose Hypofractionation 1Practice Guidelines as Topic 1Minoxidil 1Immunoglobulin G 1Imlunestrant 1Hormones 1High-Energy Shock Waves 1Goserelin 1Genetic Testing 1Disulfides 1Cyclophosphamide 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Anatomic Stage I Breast Cancer AJCC v8 × Hormones × Clear all
NCT07407920 2026-02-12

Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
120 enrolled
Breast

Anatomic Stage I Breast Cancer AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡